Thanks to KenChowder who brought to my attention the following:

https://www.tandfonline.com/doi/full/10.1080/...ccess=true

which adds to the point of this post.

Quote:

---

We focus on cancer cell membrane molecules, hyperactive intracellular signaling pathways, and the tumor microenvironment (TME) based on their druggability, therapeutic potency, specificity to TNBC, and application in immunotherapy.

---

and

Quote:

---

Further, combination treatment targeting multiple pathways in both the TNBC tumor and its TME is essential for effective disease control.

---

Quote:

---

Because of molecular heterogeneity and differential expression of targets, current targeted treatments for TNBC are limited. Therefore, developing a novel effective targeted therapy for TNBC is an urgent unmet need.

---

Precisely at the Point Ken!

Thank you, awesome find!
If anyone has the full article...